Form 4: TransDigm CFO Sarah Wynne Reports Stock Option Exercise and Sale of Shares Under 10b5-1 Plan

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, reported the exercise of stock options and subsequent sale of common stock on June 12, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Sarah Wynne, Chief Financial Officer of TransDigm Group INC (TDG), reported transactions on June 12, 2025, as detailed in a Form 4 filing.
• Ms. Wynne exercised 3,200 stock options at an exercise price of $559.78 per share.
• Concurrently, she disposed of a total of 3,200 shares of common stock through multiple sales.
• The sales included 1,101 shares at an average weighted price of $1,451.3047, 1,897 shares at an average weighted price of $1,452.4779, and 202 shares at an average weighted price of $1,453.6034.
• These transactions were conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following these reported transactions, Ms. Wynne directly beneficially owns 3,400 shares of common stock and indirectly owns 10 shares through her husband, totaling 3,410 shares.
• She also retains 6,800 unexercised stock options.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While it's an insider sale, the transaction was pre-arranged under a 10b5-1 plan, which mitigates concerns about immediate insider sentiment. The significant profit realized by the CFO from the option exercise and sale could be viewed as a positive indicator of the stock's value for long-term holders.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-scheduled sales and not a reaction to immediate market conditions or a lack of confidence.
• The sale prices of the common stock (ranging from $1,451.00 to $1,453.79) are significantly higher than the exercise price of the options ($559.78), indicating a substantial realized gain for the insider.

Negatives

• An insider sale, even if pre-arranged, can sometimes be perceived with caution by the market as it reduces the insider's direct equity stake in the company.

Future Outlook

This Form 4 filing is a disclosure of insider transactions and does not contain any forward-looking statements or guidance regarding TransDigm Group's future performance, strategic direction, or financial outlook.

Industry Context

This Form 4 filing reports an individual insider transaction for TransDigm Group, a company primarily involved in the aerospace and defense industry. Such filings are routine regulatory disclosures and do not typically provide broader industry context, trends, or competitive analysis, focusing solely on changes in individual insider ownership.

Related Party Transactions

• Indirect beneficial ownership of 10 common shares by Sarah Wynne's husband is noted in the filing.

Stakeholder Impact

• Shareholders: The sale by a key executive, even if pre-arranged, might be viewed with mixed sentiment. However, the execution under a 10b5-1 plan generally suggests a planned liquidity event rather than a reaction to negative company prospects. The substantial profit realized by the CFO from the option exercise and subsequent sale could be interpreted as a positive sign of the stock's performance and value creation for long-term investors.

Key Dates

Keywords

TransDigm Group, TDG, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Sarah Wynne, Chief Financial Officer, 10b5-1 Plan, Beneficial Ownership